Giovanna Liuzzo Selected Research

Giovanna Liuzzo Research Topics

Disease

21	Acute Coronary Syndrome 12/2022 - 06/2003
12	Unstable Angina 09/2009 - 07/2002
9	Stable Angina 01/2018 - 07/2002
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2007
8	ST Elevation Myocardial Infarction 08/2021 - 11/2008
8	Inflammation (Inflammations) 08/2021 - 05/2006
8	Atherosclerosis 01/2021 - 02/2008
7	Myocardial Infarction 02/2014 - 02/2002
6	Thrombosis (Thrombus) 01/2022 - 11/2007
6	Cardiovascular Diseases (Cardiovascular Disease) 08/2018 - 11/2008
5	COVID-19 02/2022 - 12/2020
5	Atrial Fibrillation 01/2022 - 08/2011
5	Heart Failure 01/2022 - 09/2007
4	Ischemia 03/2022 - 07/2002
4	Myocardial Ischemia (Ischemic Heart Diseases) 10/2021 - 02/2003
4	Atherosclerotic Plaque (Atheroma) 08/2021 - 12/2007
4	Infarction (Infarctions) 11/2008 - 06/2005
3	Type 2 Diabetes Mellitus (MODY) 12/2021 - 02/2009
3	Non-ST Elevated Myocardial Infarction 01/2021 - 03/2015
3	Infections 02/2014 - 02/2003
3	Insulin Resistance 01/2013 - 08/2010
2	Chronic Renal Insufficiency 12/2021 - 11/2020
2	Weight Loss (Weight Reduction) 01/2021 - 01/2014
2	Obesity 01/2021 - 01/2021
2	Immune System Diseases (Immune Disorders) 06/2017 - 10/2009
2	Death (Near-Death Experience) 02/2014 - 02/2008
2	Hypoxia (Hypoxemia) 12/2012 - 09/2007
2	Cardiomyopathies (Cardiomyopathy) 08/2009 - 09/2007
2	Ventricular Remodeling 11/2008 - 08/2007
2	Pathologic Constriction (Stenosis) 05/2007 - 07/2002
1	MINOCA 12/2022
1	Disease Progression 04/2022
1	Myocarditis (Carditis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Rupture 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Hemorrhage 11/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021
1	Severe Acute Respiratory Syndrome 06/2021
1	Pneumonia (Pneumonitis) 06/2021
1	Overweight 01/2021
1	Pericarditis 01/2021

Drug/Important Bio-Agent (IBA)

17	C-Reactive ProteinIBA 06/2021 - 02/2002
5	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2003
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2007
3	Biological ProductsIBA 03/2022 - 07/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2017
3	Perilipin-2IBA 08/2021 - 01/2018
3	LipidsIBA 01/2021 - 10/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017 - 11/2008
3	Insulin (Novolin)FDA Link 01/2013 - 08/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022 - 05/2009
2	Heparin (Liquaemin)FDA LinkGeneric 02/2022 - 10/2021
2	AnticoagulantsIBA 01/2022 - 10/2021
2	Factor XIa (Coagulation Factor XIa)IBA 01/2022 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 12/2021 - 01/2018
2	Colchicine FDA LinkGeneric 10/2021 - 10/2020
2	omega-Chloroacetophenone (Mace)IBA 10/2021 - 02/2014
2	AntigensIBA 06/2021 - 06/2005
2	Fibrinogen (Factor I)FDA Link 06/2021 - 02/2008
2	TroponinIBA 08/2019 - 11/2003
2	InflammasomesIBA 08/2018 - 06/2017
2	EnzymesIBA 12/2017 - 07/2002
2	LipopolysaccharidesIBA 12/2017 - 01/2007
2	Atorvastatin (Lipitor)FDA Link 03/2017 - 11/2008
2	salicylhydroxamic acid (SHAM)IBA 02/2016 - 09/2007
2	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 09/2007
2	erucylphosphocholineIBA 01/2014 - 11/2008
2	LeptinIBA 06/2011 - 08/2010
2	CytokinesIBA 03/2011 - 05/2006
1	COVID-19 VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Valsartan (Vals)FDA Link 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	finerenoneIBA 12/2021
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 12/2021
1	Metalloproteases (Metalloproteinases)IBA 06/2021
1	Factor VIII (Coagulation Factor VIII)IBA 06/2021
1	fibrin fragment D (D-dimer)IBA 06/2021
1	Hemostatics (Antihemorrhagics)IBA 06/2021
1	ThrombospondinsIBA 06/2021
1	DisintegrinsIBA 06/2021
1	von Willebrand FactorIBA 06/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021

Therapy/Procedure

7	Therapeutics 12/2022 - 11/2008
7	Percutaneous Coronary Intervention 01/2022 - 12/2007
2	Precision Medicine 12/2022 - 01/2016
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 06/2017
2	Ligation 01/2021 - 09/2007
2	Stents 01/2018 - 02/2014
1	Conservative Treatment 01/2022
1	Dual Anti-Platelet Therapy 01/2021